We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 420 results
  1. Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours

    Li-Fraumeni Syndrome (LFS), caused by germline pathogenic variants in TP53 , predisposes to a wide range of young-onset malignancies, particularly...

    Douglas Tjandra, Alex Boussioutas in Familial Cancer
    Article Open access 11 January 2024
  2. Factors affecting adherence to a high-risk surveillance protocol among patients with Li-Fraumeni syndrome

    Background

    High-risk surveillance for patients with Li-Fraumeni syndrome (LFS) has shown a stage shift and improved overall survival, but is...

    Kaylee A. Underkofler, Martha H. Thomas, ... Kari L. Ring in Hereditary Cancer in Clinical Practice
    Article Open access 11 August 2023
  3. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases

    Li-Fraumeni syndrome (LFS) is an autosomal dominant tumor predisposition syndrome caused by heterozygous germline mutations or deletions in the TP53 ...

    Yuji Kibe, Fumiharu Ohka, ... Ryuta Saito in Acta Neuropathologica Communications
    Article Open access 11 April 2024
  4. Li-Fraumeni Syndrome

    Li-Fraumeni syndrome (LFS) is a prototypic cancer susceptibility syndrome, resulting from germline pathogenic variants in the tumor suppressor gene,...
    Anita Villani, Thierry Frebourg, David Malkin in The Hereditary Basis of Childhood Cancer
    Chapter 2021
  5. Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report

    Background

    Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary cancer syndrome caused by pathogenic variants in the gene TP53 . This gene...

    Juan Pablo Arango-Ibañez, Luis Gabriel Parra-Lara, ... Lisa **mena Rodríguez-Rojas in Hereditary Cancer in Clinical Practice
    Article Open access 18 January 2024
  6. Li–Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype–phenotype correlation

    Background

    Li–Fraumeni syndrome (LFS) is a rare autosomal hereditary predisposition to multiples cancers, mainly affecting young individuals. It is...

    Hela Sassi, Rym Meddeb, ... Ridha M’rad in BMC Medical Genomics
    Article Open access 04 March 2022
  7. Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report

    Background

    Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent...

    Alexander Puzik, Markus Uhl, ... Udo Kontny in Hereditary Cancer in Clinical Practice
    Article Open access 20 October 2021
  8. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome

    Ixtaccihuatl H. Obregón, Kelvin C. de Andrade, ... Sharon A. Savage in Familial Cancer
    Article 11 January 2023
  9. Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome

    Comprehensive annual screening reduces cancer-related mortality in Li-Fraumeni syndrome (LFS), a cancer-prone disorder caused by pathogenic germline TP53...

    Leatrisse Oba, Ana F. Best, ... Payal P. Khincha in Familial Cancer
    Article 02 June 2021
  10. Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome

    Background

    Li-Fraumeni Syndrome (LFS) is a cancer predisposition syndrome characterized by the early-onset of multiple primary cancers which can occur...

    Ofelia Cruz, Victoria Caloretti, ... Cinzia Lavarino in Hereditary Cancer in Clinical Practice
    Article Open access 06 January 2021
  11. Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome

    Léa Guerrini-Rousseau, Arnault Tauziède-Espariat, ... Marie-Anne Debily in Acta Neuropathologica Communications
    Article Open access 06 January 2023
  12. Simultaneous diagnosis of liver PEComa in a family with known Li–Fraumeni syndrome: a case report

    Background

    Li–Fraumeni syndrome (LFS) is an autosomal dominant hereditary disease. It is associated with the loss of function of the p53 protein and...

    María del Mar Galera López, Iván Márquez Rodas, ... Rosa Álvarez Álvarez in Clinical Sarcoma Research
    Article Open access 24 November 2020
  13. Current prospects of hereditary adrenal tumors: towards better clinical management

    Adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL) are two rare types of adrenal gland malignancies. Regarding hereditary...

    Akihiro Ohmoto, Naomi Hayashi, ... Arisa Ueki in Hereditary Cancer in Clinical Practice
    Article Open access 26 March 2024
  14. Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome

    Li-Fraumeni syndrome (LFS) is an inherited cancer syndrome, characterized by an early onset of various types of cancers. LFS is associated with a...

    S. A. Nieuwenburg, F. Adan, ... M. B. Crijns in Familial Cancer
    Article 30 April 2020
  15. Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent

    TP53 pathogenic variants cause Li-Fraumeni syndrome (LFS), with some variants causing an attenuated phenotype. Herein, we describe the clinical...

    Johnathan Arnon, Aviad Zick, ... Shiri Shkedi-Rafid in Familial Cancer
    Article Open access 14 May 2024
  16. Waiting and “weighted down”: the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome

    Li-Fraumeni Syndrome (LFS) is characterized by risk of multiple primary malignancies in diverse sites, pediatric onset, near complete penetrance by...

    Allison Werner-Lin, Jennifer L. Young, ... Payal P. Khincha in Familial Cancer
    Article 28 March 2020
  17. The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report

    Background

    Li-Fraumeni syndrome is a cancer predisposition syndrome caused by germline TP53 tumor suppressor gene mutations, with no previous...

    John G. Aversa, Francine Blumental De Abreu, ... Naris Nilubol in BMC Cancer
    Article Open access 30 March 2020
  18. Cancer surveillance for individuals with Li-Fraumeni syndrome

    Christian P. Kratz, Anita Villani, ... David Malkin in European Journal of Human Genetics
    Article 19 August 2020
  19. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

    Fifty years after the recognition of the Li–Fraumeni syndrome (LFS), our perception of cancers related to germline alterations of TP53 has...

    Thierry Frebourg, Svetlana Bajalica Lagercrantz, ... Marja Hietala in European Journal of Human Genetics
    Article Open access 26 May 2020
Did you find what you were looking for? Share feedback.